Hint mode is switched on Switch off

GRAIL, ordinary share
GRAL, US3847471014

Add a stock to WL
Choose all Reset all
GRAIL, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
GRAIL, Inc. operates as a biotechnology company. The Company focuses on combining science, technology, and clinical studies to reveal cancer at its beginings. GRAIL offers its services in the United States.
  • Issuer
  • Full borrower / issuer name
    GRAIL Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

IFRS/US GAAP reports

2025
I q eng
2024
II q eng
III q eng
IV q eng
Show all Hide

Related Stock indices

Indicators

News

05/06/2026 GRAIL, Inc. (NASDAQ:GRAL) Stock Analysis: Navigating Clinical Trial Results and Market Volatility
01/06/2026 GRAIL: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Other Events, Exhibits
20/02/2026 Grail Inc. (NASDAQ:GRAL) Faces Challenges Amid Price Target Adjustment and Trial Results
19/02/2026 GRAIL: Results Of Operations And Financial Condition, Other Events, Exhibits
13/11/2025 Guggenheim Upgrades GRAIL to Buy, Sees Major Upside in Cancer Detection Market
All organization news

Holders

Industry Leaders

Registration is required to get access.